Universal Health Services, Inc.

NYSE:UHS Stock Report

Market Cap: US$11.9b

Universal Health Services Future Growth

Future criteria checks 1/6

Universal Health Services is forecast to grow earnings and revenue by 8.3% and 6% per annum respectively. EPS is expected to grow by 10.6% per annum. Return on equity is forecast to be 17.2% in 3 years.

Key information

8.3%

Earnings growth rate

10.6%

EPS growth rate

Healthcare earnings growth20.7%
Revenue growth rate6.0%
Future return on equity17.2%
Analyst coverage

Good

Last updated18 Dec 2024

Recent future growth updates

Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Apr 26
Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

Universal Health Services: A Healthy Business That Should Translate To Healthy Upside

Dec 04

Is Universal Health Services (NYSE:UHS) A Risky Investment?

Nov 27
Is Universal Health Services (NYSE:UHS) A Risky Investment?

Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings

Nov 10
Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings

Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down

Sep 26
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down

Universal Health Services: Stock Has Lots Of Upside Runway

Sep 17

Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings

Aug 10
Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings

We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt

Jul 26
We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt

Universal Health Services: An Underpriced Healthy Business

Jul 04

Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?

Jun 25
Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?

Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down

Jun 10
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down

This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate

May 09
This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate

Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Apr 26
Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings

Apr 17
Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings

Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 01
Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets

Is Universal Health Services (NYSE:UHS) Using Too Much Debt?

Feb 20
Is Universal Health Services (NYSE:UHS) Using Too Much Debt?

Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends

Feb 05
Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends

With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For

Jan 09
With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For

Universal Health Services: Seeking A Cure For Flat Performance

Sep 11

Universal Health Services: Business Is On The Mend

Jul 12

Universal Health Services Q4 2022 Earnings Preview

Feb 24

Universal Health: Retain Buy As Systematic Defensive Overlay

Feb 04

Universal Health Services declares $0.20 dividend

Jan 18

Universal Health Services upgraded at Wells Fargo on improving operating environment

Jan 03

Universal Health Services: Attractive Even In Light Of Cost Concerns

Nov 14

Earnings and Revenue Growth Forecasts

NYSE:UHS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202617,6321,2481,1201,97914
12/31/202516,6951,1729681,79816
12/31/202415,7211,0861,0741,82315
9/30/202415,4181,0269571,861N/A
6/30/202415,0189348331,690N/A
3/31/202414,6588165911,373N/A
12/31/202314,2827175251,268N/A
9/30/202314,0256764121,113N/A
6/30/202313,7996925091,172N/A
3/31/202313,574684139841N/A
12/31/202213,399675262996N/A
9/30/202213,2287392611,021N/A
6/30/202213,0487744821,242N/A
3/31/202212,9229354691,257N/A
12/31/202112,64299048884N/A
9/30/202112,4541,059-124704N/A
6/30/202112,2101,0811701,028N/A
3/31/202111,7421,0081,1341,930N/A
12/31/202011,5599411,6262,360N/A
9/30/202011,3688781,8422,552N/A
6/30/202011,2787341,5412,217N/A
3/31/202011,4047218471,509N/A
12/31/201911,3788137831,438N/A
9/30/201911,2377267781,430N/A
6/30/201911,0638016961,340N/A
3/31/201910,8897896141,297N/A
12/31/201810,7727795741,275N/A
9/30/201810,6618405851,254N/A
6/30/201810,554810N/A1,256N/A
3/31/201810,485770N/A1,110N/A
12/31/201710,410752N/A1,248N/A
9/30/201710,243707N/A1,076N/A
6/30/201710,111717N/A1,031N/A
3/31/20179,929717N/A1,342N/A
12/31/20169,766702N/A1,334N/A
9/30/20169,606702N/A1,361N/A
6/30/20169,424700N/A1,326N/A
3/31/20169,268697N/A1,225N/A
12/31/20159,043680N/A1,068N/A
9/30/20158,905679N/A1,143N/A
6/30/20158,716612N/A1,109N/A
3/31/20158,492581N/A1,113N/A
12/31/20148,205545N/A1,036N/A
9/30/20147,830497N/A998N/A
6/30/20147,607529N/A952N/A
3/31/20147,391529N/A900N/A
12/31/20137,368510N/A884N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: UHS's forecast earnings growth (8.3% per year) is above the savings rate (2.6%).

Earnings vs Market: UHS's earnings (8.3% per year) are forecast to grow slower than the US market (15.2% per year).

High Growth Earnings: UHS's earnings are forecast to grow, but not significantly.

Revenue vs Market: UHS's revenue (6% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: UHS's revenue (6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: UHS's Return on Equity is forecast to be low in 3 years time (17.2%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:07
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Universal Health Services, Inc. is covered by 40 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hua HaBaird
Adam FeinsteinBarclays
Andrew MokBarclays